Golden, Emily
Rashwan, Rabab
Woodward, Eleanor A.
Sgro, Agustin
Wang, Edina
Sorolla, Anabel http://orcid.org/0000-0001-8238-8763
Waryah, Charlene
Tie, Wan Jun
Cuyàs, Elisabet
Ratajska, Magdalena http://orcid.org/0000-0001-7015-1865
Kardaś, Iwona
Kozlowski, Piotr http://orcid.org/0000-0003-3770-7715
Johnstone, Elizabeth K. M. http://orcid.org/0000-0001-7990-371X
See, Heng B.
Duffy, Ciara
Parry, Jeremy
Lagerborg, Kim A. http://orcid.org/0000-0002-9101-0022
Czapiewski, Piotr
Menendez, Javier A.
Gorczyński, Adam
Wasag, Bartosz http://orcid.org/0000-0002-3634-7562
Pfleger, Kevin D. G.
Curtis, Christina http://orcid.org/0000-0003-0166-3802
Lee, Bum-Kyu
Kim, Jonghwan http://orcid.org/0000-0002-9919-9843
Cursons, Joseph http://orcid.org/0000-0002-5053-4540
Pavlos, Nathan J.
Biernat, Wojciech http://orcid.org/0000-0001-8462-2189
Jain, Mohit
Woo, Andrew J. http://orcid.org/0000-0003-1198-6373
Redfern, Andrew
Blancafort, Pilar http://orcid.org/0000-0002-3881-7396
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1130212, APP1069308, APP1147528)
Article History
Received: 31 October 2020
Accepted: 25 February 2021
First Online: 26 March 2021
Competing interests
: A.R. acts in an advisory capacity to Pfizer (who make an mTOR inhibitor and a CDK 4/6 inhibitor), Novartis (who make a CDK 4/6 inhibitor) as well as AstraZeneca and Roche. J.C. is an employee of oNKo-Innate Pty Ltd. K.P. received funding from Promega, BMG Labtech, and Dimerix as ARC Linkage Grant participating organizations. These participating organizations played no role in any aspect of the conception or design of the research, collection, analysis, and interpretation of the results, or writing and editing of the paper. K.P. is the chief scientific advisor of Dimerix, of which he maintains a shareholding. All other authors declare no competing interests.